Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether sequential application of low-dose
short-term sunitinib and chemotherapy is effective in the treatment of non-small cell lung
cancer after failure of conventional therapy. Safety of this regimen will also be evaluated.